TC Biopharm (TCBPW) Competitors $0.0060 0.00 (-38.14%) As of 03/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesTrendsBuy This Stock TCBPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALAShould you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. TC Biopharm vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences 180 Life Sciences (NASDAQ:ATNFW) and TC Biopharm (NASDAQ:TCBPW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, valuation and community ranking. Which has better earnings and valuation, ATNFW or TCBPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ATC Biopharm$2.86MN/AN/AN/AN/A Does the media refer more to ATNFW or TCBPW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled TC Biopharm'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral TC Biopharm Neutral Does the MarketBeat Community favor ATNFW or TCBPW? 180 Life Sciences and TC Biopharm both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ATC BiopharmN/AN/A Is ATNFW or TCBPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A TC Biopharm N/A N/A N/A SummaryTC Biopharm beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Remove Ads Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCBPW vs. The Competition Export to ExcelMetricTC BiopharmBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$110.36M$5.20B$7.53BDividend YieldN/A3.69%5.34%4.26%P/E RatioN/A2.9721.6917.98Price / SalesN/A3,723.67347.0490.12Price / CashN/A13.0138.1534.64Price / BookN/A31.486.143.88Net IncomeN/A-$87.82M$3.19B$247.26M7 Day PerformanceN/A-3.69%-4.94%-5.24%1 Month PerformanceN/A55.90%-3.24%-8.65%1 Year PerformanceN/A71.96%3.15%-6.15% TC Biopharm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCBPWTC BiopharmN/A$0.01-38.1%N/A-76.2%$0.00$2.86M0.0080Gap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.01flatN/A-15.5%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03-4.1%N/A-84.9%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.11-8.3%N/AN/A$0.00$20,729.000.0040Positive NewsGap DownALVOWAlvotechN/A$1.40-7.3%N/A-67.1%$0.00$489.68M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-44.0%$0.00N/A0.0015BFRIWBiofronteraN/A$0.06-36.2%N/A+20.0%$0.00$37.32M0.0070BTMDWbioteN/A$0.06-2.4%N/AN/A$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.10-0.1%N/A-92.8%$0.00N/A0.008Positive NewsGap DownCALACalithera BiosciencesN/A$0.00-83.3%N/A-96.7%$0.00N/A0.0060Analyst ForecastGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Calithera Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TCBPW) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
